WILLIAM E. ROTE

CIK 1698262 · Chief Research Officer · last filed 2026-05-06

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$6.15M

Companies

2

Total Filings

47

Lifetime Open-Market Net

-$5.22M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TVTX Chief Research Officer 118,237 $52.04 $6.15M -$4.65M 28 2026-05-06
Travere Therapeutics, Inc. (RTRX) Delisted Senior Vice President, R&D 24,086 -$567.0K 19 2020-11-17

Recent Filings · Page 2 of 5

47 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-02-02 TVTX Mixed +20,236 -$41.5K EDGAR
2024-01-25 TVTX Sell (S) −2,062 -$18.5K EDGAR
2023-09-05 TVTX Mixed +1,485 -$26.7K EDGAR
2023-05-12 TVTX Sell (S) −825 -$13.7K EDGAR
2023-02-02 TVTX Mixed +17,660 -$57.6K EDGAR
2023-01-26 TVTX Sell (S) −2,062 -$44.3K EDGAR
2022-05-12 TVTX Sell (S) −1,563 -$33.9K EDGAR
2022-02-02 TVTX Mixed +8,715 -$30.8K EDGAR
2022-01-26 TVTX Sell (S) −1,875 -$46.8K EDGAR
2022-01-12 TVTX Mixed +2,500 -$68.5K EDGAR
Showing 1120 of 47
Page 2 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.